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PhospholipidTAT peptide is one of the best-characterized cell penetrating peptides derived from the transactivator of
transcription protein from the human immunodeﬁciency virus 1. The aim of this study was to investigate
the interaction between TAT peptide and partially negatively-charged phospholipid bilayer by using lamellar
neutron diffraction. The main ﬁndings are the existence of a contiguous water channel across the bilayer in
the presence of TAT peptide. Taken in combination with other observations, including thinning of the lipid
bilayer, this unambiguously locates the peptide within the lipid bilayer. The interaction of TAT peptide
with anionic lipid bilayer, composed of an 80:20 mixture of DOPC and DOPS, takes place at two locations.
One is in the peripheral aqueous phase between adjacent bilayers and the second is below the glycerol back-
bone region of bilayer. A membrane thinning above a peptide concentration threshold (1 mol%) was found,
as was a contiguous transbilayer water channel at the highest peptide concentration (10 mol%). This evi-
dence leads to the suggestion that the toroidal pore model might be involved in the transmembrane of TAT
peptide. We interpret the surface peptide distribution in the peripheral aqueous phase to be a massive exclu-
sion of TAT peptide from its intrinsic location below the glycerol backbone region of the bilayer, due to the
electrostatic attraction between the negatively-charged headgroups of phospholipids and the positively
charged TAT peptides. Finally, we propose that the role that negatively-charged headgroups of DOPS lipids
play in the transmembrane of TAT peptide is less important than previously thought.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Over the past decades, the low permeability of cell membranes
and poor targeting have placed severe restrictions on pharmaceutical
development. A number of strategies have been designed to circum-
vent these limitations, such as liposomes, microspheres, microinjec-
tion and adenovirus vectors, but few of these methods have been
applied effectively in vivo at a clinical level [1–5]. A group of short
polycationic or amphipathic sequences, so-called cell penetrating
peptides (CPPs), have attracted much interest, due to their remark-
able capacity for passive membrane translocation with low immuno-
genicity and no toxicity [6,7].
CPPs are a diverse group of 100 or so peptides that are able to
cross the cell membrane and deliver various biomolecules into cells;
these include oligonucleotides, DNA, siRNA, peptides and proteins as
well as liposomes [8–11]. They are regarded as one of the most prom-
ising therapeutic tools for non-invasive delivery of macromolecules
into cells [12,13], and are therefore likely to play a key role in the: +44 131 650 6576.
l rights reserved.future of disease treatments. One of the best-characterized CPPs
is derived from the transactivator of transcription (TAT) protein
from the human immunodeﬁciency virus 1 (HIV-1). The minimal
peptide sequence of TAT protein responsible for cellular uptake is
47YGRKKRRQRRR57 [14], which contains six arginine and two lysine
residues and therefore possesses a high net positive charge at physi-
ological pH levels.
Although TAT peptide has been successfully employed for the deliv-
ery into cells of a wide variety of compounds [15–20], the exact mech-
anism of internalization still remains a subject of controversy. Initially,
internalization of TAT peptide was understood in terms of cellular
endocytosis-mediated uptake, such as clathrin-mediated endocytosis,
caveolae-mediated endocytosis, lipid-raft mediated caveolae endo-
cytosis and macropinocytosis [21–25]. In contrast, other reports have
favored a direct translocation process that was independent of endocy-
tosis, of temperature, and of a speciﬁc receptor, such as transient pore
formation, inverted micelles involvement and electroporation-like per-
meabilization, thereby excluding endocytosis [26–29]. Regardless of the
uncertainty of the transmembrane mechanism, it is generally believed
that the strong electrostatic attraction between positively-charged
TAT peptide and negatively-charged headgroups of phospholipid is a
prerequisite for the translocation of peptide [30–34].
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TAT peptide acts is that, experimentally, it has proved impossible to
observe the insertion of an individual TAT peptide into a plasma
membrane in atomic detail. A myriad of indirect physical methods,
including ﬂuorescence spectroscopy, differential scanning calorime-
try (DSC), isothermal titration calorimetry and nuclear magnetic res-
onance (NMR), has been employed to localize TAT peptide within
model lipid membranes [31–37]. However, they have yielded equivo-
cal and sometimes contradictory results.
With the aim of seeking unambiguous evidence of the location of
TAT peptide within lipid bilayers, we employed a direct and sensitive
method — neutron lamellar diffraction in combination with H2O/D2O
substitution. This is the ﬁrst studywe knowof inwhich neutron diffrac-
tion was used to observe the interaction of TAT peptide with model
phospholipid bilayers. The dioleoylphosphatidylcholine (DOPC) and
dioleoylphosphatidylserine (DOPS) were initially considered as model
membrane systems because their acyl chains are in the ﬂuid-phase
state at the temperature at which our experiments were performed
(25 °C), thereby modeling the conditions of a cell membrane under
physiological conditions. A mixture of 80:20 mol/mol of DOPC and
DOPS phospholipid was used to mimic the negatively-charged state of
cell membranes without increasing the complexity of the membrane
system unnecessarily. This study gives new insights into the molecular
details of the interaction TAT peptide and model anionic model
membranes.
2. Materials and methods
2.1. Chemicals
The 11 amino acid TAT peptide (47YGRKKRRQRRR57) was synthe-
sized by Almac Sciences Ltd. (20 Castle Terrace, Edinburgh, EH1 2EN,
Scotland, U.K.) using solid-phase synthesis. The purity was >95%, as
determined by analytical HPLC, MALDI-TOF mass spectrometry, and
amino acid analysis.
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-
sn-glycero-3-phosphoserine (DOPS) were purchased from Avanti Polar
Lipids Inc., USA, and used without further puriﬁcation. Chloroform,
methanol and buffers were all graded AR and purchased from Sigma-
Aldrich (Irvine, UK).
2.2. Neutron diffraction
Partially negatively-charged lipid mixture samples were measured
on the small momentum transfer diffractometer D16 at the Institut
Laue et Langevin (ILL), Grenoble, France. Firstly, TAT peptide was
dissolved in Millipore water at 20 mg/mL as a stock solution. Then,
20 mg of an 80:20 (mol%) mixture of DOPC and DOPS were dissolved
in chloroform, adding different amounts of TAT peptide stock solution
at speciﬁc peptide-to-lipid molar ratios (0.1–10 mol%), and ﬁnally
deposited onto quartz microscope slides (75 mm × 25 mm) by a
nitrogen-propelled airbrush. This results in multilayer stacks of highly
aligned bilayers. The slides were then placed in a vacuum desiccator
for over 12 h in order to remove all traces of the solvent. The samples
were protected from light whenever possible in order to reduce the
chance of lipid peroxidation. The sample environment was a standard
aluminum can, in which temperature control was achieved by circulat-
ing water through an integral water jacket and the humidity was con-
trolled by slightly adjusting the temperatures of the solutions in the
two Teﬂon water troughs at the base of the can. Before measurements
were made, each sample was hydrated in a backup aluminum can for
at least 6 h at a relative humidity of 95%, 97%, and 99%, respectively,
and the D2O concentration was set to 8.06% or 25% (v/v) for each level
of relative humidity [38]. Finally, the fully equilibrated sample was
quickly transferred straight into the test can and a series of continuous
θ–2θ scans were initiated immediately (from θ = 1.5 to 20.0°). Allsamples were run at 25 °C. Each scan took approximately 3 h to com-
plete and 5 orders of Bragg diffraction were collected. The mosaic
spread of the ﬁrst order of diffraction was determined for each sample
using standard procedures. The diffraction intensity was obtained
from the detector counts according to the pixel response, and the
diffraction images were then collapsed into a linear spectrum for each
scan using D16 instrument software LAMP. Background subtraction
and peak ﬁtting were performed using PeakFit (SPSS Software).
Gaussian distributions were then ﬁtted to the Bragg peaks and the an-
gular position, width and intensity of each peak were recorded. Raw
data correction and structure factor amplitude calculations proceeded
as previously described [38]. Brieﬂy, themethod takes the peak intensi-
ties for each order (Ih) and corrects for neutron absorption (Cabs) and
the Lorentz factor (Clor), resulting in the discrete structure factor ampli-
tudes F(h). Geometry corrections were not needed for the D16 instru-
ment. The two corrections are given by
Clor ¼ sin 2θ ð1Þ
Cabs ¼
α
1−e−αð Þ ;α ¼
2μt
sin θ
ð2Þ
where μ is the absorption coefﬁcient, t is the sample thickness, σ is the
width of the beam, and μ is the calculated absorption coefﬁcient. The
structure factor amplitudes were calculated by taking the square-root
of the corrected peak intensities:
F hð Þj j ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
CabsCabsIh
p
: ð3Þ
Above corrected structure factors F(h) were then used for the sub-
sequent Fourier transformation in following section.
2.3. Neutron data analysis
Firstly, the D-repeat (Bragg repeat spacing, d) was calculated by
least-squares ﬁtting of the observed angles of diffraction (2θ) to the
Bragg equation:
nλ ¼ 2d sin θ ð4Þ
where n is the order of diffraction, λ is the wavelength of neutrons
and θ is the scattering angle.
The structure factors obtained from the same sample at 8.06% D2O
with three different relative humidities can be simultaneously ﬁtted
to a single continuous transform in reciprocal space using Shannon's
sampling theorem. The procedure was repeated as previously de-
scribed [39], least-squares ﬁtting the data to sets of model structure
factors F(H), each corresponding to a D-repeat of D, and satisﬁed
the following equation:
F hð Þ ¼ ∑
Hmax
H¼0
F Hð Þ sin
πDh
d −πH
 
πDh
d −πH
  ð5Þ
where F(H) are the sets of model structure factors, F(h) values are the
observed structure factors and d is the Bragg repeat spacing.
Finally, phased and scaled structure factors F(h) and Bragg repeat
spacings were used to reconstruct coherent relative absolute density
proﬁle by Fourier synthesis:
ρ xð Þ ¼ ρ 0ð Þ þ 2
d
∑
Hmax
H¼0
F hð Þ cos 2πxh
d
 
ð6Þ
where ρ(0) is the average scattering density per unit length of the bi-
layer, x is the distance along the bilayer normal, F(h) are the scaled
structure factors, and the sum describes the distribution in scattering
lengths across the bilayer.
Table 2
d-repeat and bilayer thickness of DOPC/DOPS bilayer in presence and absence of TAT
peptide at 99%RH, with 8% 2H2O.
P/L ratio 0% 0.1% 1% 10%
d-repeat (Å) 52.55 ± 0.40 52.62 ± 0.41 52.53 ± 0.37 54.62 ± 0.40
Bilayer thickness (Å) 34.97 ± 0.30 34.97 ± 0.30 33.94 ± 0.26 33.94 ± 0.26
1984 X. Chen et al. / Biochimica et Biophysica Acta 1828 (2013) 1982–1988As the fact that the bilayer is composed of twomonolayers, the av-
erage scattering density per unit cell ρ(0) can be estimated by sum-
ming the coherent scattering lengths of the atoms that comprise the
unit cell.
ρ 0ð Þ ¼ 2=dð Þ nwbw þ blip
 
ð7Þ
where nw is the number of waters per lipid, bw is the coherent scat-
tering length of water and blip is the coherent scattering length from
a single lipid molecule.
Furthermore, to estimate the signiﬁcance of any feature in the
scattering length density proﬁles, the errors of the proﬁles were
calculated by [40]
Δρ xð Þ ¼ 2t
d
∑
Hmax
H¼0
ΔF hð Þð Þ2 cos2 2πxh
d
 " #12
ð8Þ
where Δρ(x) is the error in x at a conﬁdence limit of 95%, t is the
Student's t factor (1.96) and ΔF(h) are the structure factor errors
from the ﬁtting process described by Eq. (5).
3. Results and discussion
3.1. D-repeat and bilayer thickness
The isotopic substitution method is the most widely used but
time-consuming approach to scale the structure factors from neutron
scattering data. In 1998, Bradshaw et al. ﬁrstly introduced the
swelling-series method that can improve both the accuracy of struc-
ture factors measurement and reduce sample equilibration time
[38]. The key point of this method is to collect the neutron data at
8.06% D2O. At this isotopic composition, the negative scattering of hy-
drogen nuclei is exactly balanced by the positive scattering of oxygen
and deuterium nuclei, leading the scattering length density of the
water layer is zero [41]. It allows less ambiguous interpretation of
the results. Furthermore, the low level of radiation damage of neu-
trons, due to their non-charged and weak interaction properties,
allows several selling-series points can be collected from the same
sample. In practice, as the sample was not disturbed between mea-
surements, the requirement for scaling between measurements in
the same swelling series was not needed. Another advantage of the
swelling-series method was that any bilayer disturbance and modiﬁ-
cation induced by peptide or protein would have a direct reﬂection in
the lipid scattering length density (SLD) proﬁle, due to the strong
positive scattering length from their chemical compositions like car-
bon, nitrogen, and oxygen. It was straightforward to locate the pep-
tide distribution through the bilayer by comparing the lipid SLD
proﬁles in the presence and absence of peptide.
All the experimentally derived structure factors used to calculate
transbilayer SLD proﬁles in the presence of 8.06 mol% D2O, including
the form factor errors from the ﬁtting procedure as described in
Methods, are summarized in Table 1.
From Table 2, the D-repeat of DOPC/DOPS (80:20) mixture bilayer,
calculated using the Bragg equation from 5 orders of diffraction at a
relative humidity of 99%, was 52.55 ± 0.40 Å (mean ± SD, n = 5).
Interestingly, when up to 1 mol% peptide (peptide/lipid ratio) wasTable 1
Experimental determined, corrected, and scaled structure factors of DOPC/DOPS mixture lip
P/L ratio F(1) F(2)
0% −21.21 ± 0.50 −11.29 ± 0.02
0.1% −26.32 ± 0.78 −13.56 ± 0.10
1% −32.68 ± 0.01 −16.06 ± 0.34
10% −48.56 ± 0.68 −18.75 ± 0.50introduced, no signiﬁcant difference in D-repeat was found. The
D-repeats of various samples were 52.62 ± 0.41 Å and 52.53 ±
0.37 Å, for DOPC/DOPS with 0.1 mol% TAT and 1 mol% TAT, respec-
tively. These differences in D-repeat were well within the generally
accepted error limit (up to 1 Å) [42]. However, a signiﬁcant 2 Å in-
crease in D-repeat was observed at 10 mol% peptide concentration,
compared to the pure lipid (54.62 ± 0.40 Å vs. 52.55 ± 0.40 Å).
We also extracted the bilayer thickness information from the scat-
tering length density (SLD) proﬁle of lipid bilayer at 8.06% D2O, as
shown in Fig. 1, which, for this purpose, may be deﬁned as the dis-
tance between the two maxima in the proﬁle. The two maxima in a
typical bilayer proﬁle corresponded to the glycerol backbone and
phosphate headgroups. The oxygens of the ester linkages attaching
the fatty-acyl chains and head group to the glycerol, and the phos-
phorus and oxygen atoms of the headgroups increased the scattering
length density of this region. Values for the bilayer hydrophobic
thickness are presented in Table 1. When a small amount of TAT pep-
tide was ﬁrstly introduced, no difference in bilayer thickness was
found. Membrane thinning only occurred when the peptide concen-
tration reached a threshold (1 mol%). The bilayer thickness shrank
from 34.97 ± 0.30 Å for the 0.5 mol% sample to 33.94 ± 0.26 Å for
the 1 mol% sample, and remained constant when more peptides
were incorporated. The amount of thinning was not directly propor-
tional to the peptide concentration.
Taken together, the above data from D-repeat and bilayer thick-
ness showed that TAT peptide did lead to thinning of anionic mem-
branes, above a certain concentration threshold (1 mol%). Moreover,
the largest TAT peptide concentration investigated (10 mol%) might
be larger than the saturation of the insertion, thus a signiﬁcant
amount of peptide remained in the aqueous bulk between adjacent
bilayers. This would explain why a 2 Å increase in D-repeat was ob-
served at 10 mol% peptide concentration, whereas the bilayer thick-
ness remained unchanged.
3.2. Scattering length density proﬁles
As described above, under the conditions of 8.06%D2O, neutron scat-
tering by the water was eliminated and the water was effectively invis-
ible to neutrons; the resulting SLD proﬁle came from the diffraction of
the lipid only [38]. Fig. 1 shows the SLD proﬁles of pure DOPC/DOPS bi-
layers (black solid line) and of DOPC/DOPS with different amount of
TAT peptide (black broken line) at 8.06% D2O. Typical structure features
of the lamellar lipid bilayer were well represented in the pure lipid SLD
proﬁle. [43]. The origin of the x-axis was the centrosymmetric center of
the unit cell, which corresponded to the center of the bilayer. The
interlamellarwater layers lay at the two edges of theunit cell. Twomax-
ima in the proﬁle corresponded to the polar lipid headgroups, which
were a combination of glycerol-ester and phosphate moieties. A mini-
mum at the center of the proﬁle corresponded to the terminal methylid bilayers (8:2) in absence and presence of different concentrations of TAT peptide.
F(3) F(4) F(5)
8.94 ± 0.03 −5.44 ± 0.01 −2.68 ± 0.11
10.74 ± 0.13 −6.39 ± 0.21 −3.73 ± 0.01
12.17 ± 0.07 −5.99 ± 0.01 −4.35 ± 0.13
10.86 ± 0.01 −2.84 ± 0.22 −5.68 ± 0.10
Fig. 1. An illustration of neutron scattering length density (SLD) proﬁles at 8.06% 2H2O.
Pure DOPC/DOPS lipid bilayer is drawn in black solid line and of lipid with 1 mol% TAT
peptide is drawn in black broken line. The difference proﬁle calculated by subtracting
structure factors of pure lipid from structure factors of lipid with TAT peptide is
shown in red broken line. A ﬁt of two Gaussian functions to the difference proﬁle is
shown in blue solid line. From A to C, the amount of TAT peptide is increased.
Table 3
Summary of parameters of the Gaussian ﬁts of the calculated peptide (difference SLD)
proﬁles in reciprocal space. Five orders of diffraction were used in the ﬁtting procedure.
The position of TAT peptide is expressed as the distance from the center of the bilayer.
The width is the full width at half height.
TAT peptide distribution L/P = 100:0.1 L/P = 100:1 L/P = 100:10
Gaussian 1 Position (Å) 23.7 24.8 24.6
Width (Å) 3.3 5.6 5.5
Occupancy (%) 57.9 41.5 49.3
Gaussian 2 Position (Å) 15.2 14.3 13.8
Width (Å) 3.0 5.1 5.1
Occupancy (%) 42.1 58.5 50.7
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mum represented the double bond in oleoyl fatty acid chains. From the
above detailed depiction of lipid SLD proﬁle, it was convenient to use
the distance between these two maxima as an indication of bilayer
thickness, though it more precisely represented the thickness of the bi-
layer between the glycerol backbones, and did not take into account
much of the bilayer headgroup above the phosphate [44].
A series of experiments had been conducted to compare the pep-
tide distribution at different peptide concentrations (0.1 mol% to
10 mol%) in the DOPC/DOPS mixture lipid bilayer. Appropriate raw
neutron diffraction datawere phased and placed on a relative absolute
scale to reconstruct the SLD proﬁles by Fourier synthesis. In Fig. 1, thered broken line is the difference between two lipid SLD proﬁles under
8.06% D2O in the presence and absence of peptide, representing the
transbilayer peptide distribution. The difference proﬁle could be ﬁtted
as two Gaussian-shaped peaks in reciprocal space following the proce-
dure already described [38–40]. By comparing the calculated structure
factors of each difference SLD proﬁle to the observed difference struc-
ture factors, two resulting parameters from the Gaussian ﬁtting re-
vealed important information of transbilayer peptide distribution.
The ﬁrst parameter was the position of the peak, which was located
at the time-averaged center-of-mass (strictly, the center of SLD) of
TAT peptide, as measured from the center of the bilayer. The second
parameter was the width of the peak, which indicated the time-
averaged ﬂuctuation amplitude of TAT peptides across the lipid
bilayer. As shown in Fig. 1, the blue solid line was a ﬁt of a single
Gaussian function to the difference proﬁle, and whose parameters
are summarized in Table 3. It should be pointed that all comparisons
of the calculated and observed SLD proﬁles were carried out in real
space, and the Gaussian ﬁtting was carried out in reciprocal space.
From Fig. 1A, no signiﬁcant difference in the SLD proﬁles in the
presence and absence of 0.1 mol% TAT peptide were detected. How-
ever, these two SLD proﬁles did not overlap perfectly. Indeed, two
small increases of SLD density were located around the two edges of
the unit cell and the polar lipid headgroups of lipid, which were the
same positions found when higher peptide concentrations were in-
vestigated. The neutron scattering length density of the peptide is
similar to that of the phospholipids, so it is not surprising that the
changes in SLD proﬁle are so small. However, when considered in
combination with other factors, as described below, we preferred to
interpret this observation not as an experimental error but as an im-
portant clue that the intercalation of TAT peptides inside the glycerol
region of lipid and the perturbations of a lipid bilayer by TAT peptides
happened even at very low peptide content (0.1%).3.3. Peptide distribution in DOPC/DOPS lipid bilayer
From Fig. 2, and Table 3, the best ﬁts to observed peptide proﬁles
clearly demonstrated that the interaction of TAT peptide with
negatively-charged DOPC/DOPS lipid bilayer took place at two posi-
tions. A part of peptides was intercalated into the lipid/water interface
region of the bilayer at around 14.3 Å from the center of the lipid bi-
layer. The rest of peptides located in the peripheral aqueous phase be-
tween adjacent bilayers at around 24.6 Å from the center of the lipid
bilayer. With increasing peptide concentration, the ﬁrst peptide distri-
bution at lipid/water interface region started to shift toward to the cen-
ter of the lipid bilayer, whereas the second distribution at aqueous
phase did notmove. The centermass of the peptidewas found to reside
15.2 Å from the center of the bilayer at 0.1 mol% peptide concentration,
while the corresponding value for 1 mol% peptide concentration was
14.3 Å, moving 0.9 Å closer to the center of the bilayer. In the DOPC/
DOPS mixture lipid, this location was very close to the glycerol back-
bone region. Taking into account the observation that the bilayer thick-
ness of high peptide concentration sample was 1 Å thinner than that of
Fig. 2. Summary of Gaussian ﬁtting results to observed peptide (difference SLD) proﬁles
at a series of peptide concentrations, representing two TAT peptide distributions in
negatively-charged DOPC/DOPS bilayers. The interbilayer water compartment is at
the two edges of the graph. A pair of phospholipid molecules is shown above the
graph to illustrate the orientation of the lipid bilayer. The comparison is set on the
same d-repeat. From the bottom to the top, the amount of TAT peptide is increased.
The molecular structures of TAT peptide are derived from Ho et al. [45]. The hydrophilic
surface region of peptide is colored in blue, and the hydrophobic surface region is
colored in gray.
Fig. 3. Summary of Gaussian ﬁtting results to observed water (difference SLD) proﬁles
at a series of TAT peptide concentrations in negatively-charged DOPC/DOPS lipid bilay-
ers. The interbilayer water compartment is at the two edges of the graph. A pair of
phospholipid molecules is shown above the graph to illustrate the orientation of the
lipid bilayer. The comparison is set on the same d-repeat.
1986 X. Chen et al. / Biochimica et Biophysica Acta 1828 (2013) 1982–1988low concentration sample (33.9 Å vs. 34.9 Å), we suggested that TAT
peptide was at nearly the same location relative to the lipid molecule.
In addition, the width of peptide distribution showed little change
after addition of the peptide to the bilayer. Even increasing the
amount of peptide to the largest concentration (10 mol%) made little
difference to the width of peptide distribution obtained, which meant
that TAT peptide was motionally constrained to an around 5 Å region
at the lipid/water interface. Moreover, Gaussian ﬁtting to the differ-
ence SLD proﬁles also yielded the amount of TAT peptide located in
the bilayer. Interestingly, even at the lowest peptide concentration in-
vestigated (0.1 mol%), 42% of peptides were positioned below the
glycerol backbone region of the bilayer and 58% remained in the aque-
ous phase between adjacent bilayers. Such proportions of TAT peptide
distribution in the bilayer did not signiﬁcantly change over the entire
range of peptide concentrations investigated. This indicated that the
peptide has two preferred locations relative to the bilayer. It was likely
that the distribution of individual peptide molecules between the
two locations was a dynamic, rather than static, equilibrium. Unfortu-
nately the time scale of our neutron measurements did not allow this
to be determined. The bilayer proﬁles represented time-averaged dis-
tributions of neutron scattering length. The preference for the surface
location (58% of the peptide) was probably due to the electrostatic at-
traction between the negatively-charged headgroup of phospholipid
and positively charged TAT peptide.
However, the above results also strongly indicated an intrinsic af-
ﬁnity between TAT peptide and a location just below the glycerol
backbone region of the phospholipid bilayer. This was completely in
agreement with recent work reported by Su et al. [46], who proposed
that TAT peptides penetrated the glycerol backbone region of the
DMPC/DMPG bilayers and occupied a 5.5 Å region at the lipid/water
interface using Solid-State NMR.
Our ﬁndings, furthermore, raised an intriguing question as to why
TAT peptide remained at the same penetration depth and width in
the DOPC/DOPS lipid bilayer. Recently, an interesting study on CPPs
and antimicrobial peptides has suggested that the structural basis
for the rapid translocation of arginine-rich CPPs may lie in the ability
of guanidinium to form hydrogen-bond stabilized bidentate com-
plexes with lipid phosphates, which cannot be achieved by the mo-
bile amine of the Lys side chains [46]. Based on this assumption, we
prefer to think that guanidinium-phosphate ion pair interaction be-
tween the arginine residues and phosphate groups of phospholipids,
rather that the electrostatic attraction between the peptide and
negative-charged headgroups, might be the determining factor forthe membrane translocation of TAT peptide. This would be a reason-
able explanation as to why TAT preferred to locate the inner glycerol
region of phospholipid, while facing un-neglected anionic membrane
backgroups. To investigate this hypothesis, further neutron diffrac-
tions experiments focusing on the interaction between TAT peptide
and neutral zwitterionic phospholipids like DOPC are in progress.3.4. Water distribution in DOPC/DOPS lipid bilayer
Additional support for the penetration of the peptide into the lipid
bilayer was given by the water distribution across the lipid bilayer.
The dependence of the SLD proﬁle on the D2O content in water vapor
enabled the calculation of the water distribution across the bilayer by
subtracting the structure factors 8.06% D2O from those at high D2O con-
centration (25%). All ﬁttedwater proﬁles are presented in Fig. 3 for easy
comparison and the resultant parameters from the Gaussian ﬁtting are
summarized in Table 4. A typical distribution of water in the pure lipid
bilayer was ﬁttedwell by a single Gaussian peak at the two edges of the
crystallographic unit cell, representing the water layer between adja-
cent bilayers [38]. The corresponding water distribution proﬁles lipid
samples containing different TAT peptide concentrations were very
similar, and were centered around 22.5 Å from the center of the bilayer
and on 6.5 Å wide. The water distribution proﬁles in Fig. 3 show in-
creasing amounts of water as the amount of peptide increases. This
probably represented the additional water required to hydrate the pep-
tide, plus hydrogen-deuterium exchange on the peptide. Furthermore,
thewater density in the lipid hydrophobic corewasmarginal, indicating
that no water penetrated into this region at a peptide concentration
lower than 10 mol%. However, for the lipid sample with 10 mol% TAT
peptide, 16% of water population deeply intercalated inside the hydro-
phobic core at 6.2 Å from the center of the bilayer, a position close to the
double bonds of the oleoyl acyl chain. Meanwhile, the width of this
water distributionwas 3.6 Å, covering almost of whole hydrophobic re-
gion of the bilayer, which was direct evidence for the formation of a
transbilayer water channel.
Taking the above information together, the bilayer thinning, themo-
tional constraint of the peptide below the glycerol backbone region, the
discrete peptide distribution across the bilayer, and the presence of a
contiguous transbilayer water channel at a threshold concentration,
the neutron scattering data presented here unambiguously support
the carpet model of membrane perturbation induced by TAT peptide.
However, based on the well-studied pore formation models of antimi-
crobial peptides, peptide surface carpeting and bilayer thinning are
very early characteristics of peptide–membrane interactions, which
may subsequently lead to conditions allowing a local membrane
Table 4
Summary of parameters of the Gaussian ﬁts of the calculated water proﬁles in recipro-
cal space. Five orders of diffraction were used in the ﬁtting procedure. The position of
water is expressed as the distance from the center of the bilayer. The width is the full
width at half height.
Water distribution Pure
lipid
L/P = 100:0.1 L/P = 100:1 L/P = 100:10
Gaussian 1 Position (Å) 21.8 22.5 22.7 21.4
Width (Å) 5.9 6.4 6.8 5.1
Occupancy (%) 100 100 100 85.2
Gaussian 2 Position (Å) – – – 6.2
Width (Å) – – – 3.6
Occupancy (%) – – – 15.8
1987X. Chen et al. / Biochimica et Biophysica Acta 1828 (2013) 1982–1988perturbation to form a lipid–peptide toroidal pore structure or a
detergent-like disintegration of the bilayer structure [47–51].
The detergent-like model was ruled out, because in this model the
membrane would be permeated and disintegrated in a detergent like
manner without the formation of intermediate discrete water channels
[48–52]. Back to our neutron data, despite a contiguous transbilayer
water channel was observed, at least up to 5 orders of diffraction signal
were detected in the largest peptide concentration investigated
(10 mol%) (Data not shown here), strongly indicating that the bilayer
at this experimental condition remained highly lamellar in structure.
The peptide barrel-stave model was also excluded for the following
reason. Amphipathicα-helical peptides insert in a perpendicular orien-
tation to the plane of the bilayer, with the hydrophobic sides of helices
facing fatty acid chains and hydrophilic sides self-assembling a pore,
without peptide surface carpet conformation [53–55]. However, from
our CD data (data not shown here), TAT peptide mainly adopted a
random-coil structure upon interaction with the same model DOPC/
DOPS membrane (80:20) employed in this neutron diffraction experi-
ment. More importantly, the structure of the barrel-stave model
addressed the fact that TAT peptide was simply too short to span an
undisturbed lipid bilayer without thinning. A typical width 32–38 Å of
bilayerwas clearly far beyond the limit of an 11-amino acid TAT peptide
[56,57].
Thus, the toroidal pore model was strongly suggested, as the data
observed in this paper were mostly in agreement with all the detailed
aspects of the toroidal pore model. For example, a limited number of
peptides ﬁrst assembled on the lipid bilayer surface and then inserted
into the bilayer with the hydrophilic regions of the peptides associat-
ing with the phospholipid headgroups while the hydrophobic regions
associated with the lipid core [49–51]. As soon as a threshold concen-
tration of peptide was reached, a signiﬁcant rearrangement of lipid
bilayer happened and transient pores could be formed.
However, it should be noted that the amount of bilayer thinning
described in our paper was not directly proportional to the peptide
concentration, which was an obvious difference between the theoret-
ical model and the experimental data. Moreover, it was also some-
what questionable that whether the toroidal pore model was the
actual transmembrane mechanism of TAT peptide, as the contiguous
transbilayer water channel and the toroidal pore formation occurred
at an unphysiologically high threshold concentration of TAT peptide
in our experiments. Most importantly, in contrast to those arginine-
rich antimicrobial peptides (AMPs) which kill bacterial cells by
pore formation mechanism, TAT peptide appears to translocate into
eukaryotic cells without causing long-lasting damage to the integrity
of the cell membrane and at very low peptide concentrations [37,58].
The elucidation of the exact mechanism involved in the transmem-
brane of TAT peptide is complicated by these apparent discrepancies,
however, we are conﬁdent that their presence does not detract from
the valuable structural information, revealed here by the use of neu-
tron lamellar diffraction, that TAT peptide carpets the glycerol back-
bone region of the bilayer.4. Conclusion
In conclusion, our data presented the ﬁrst study of the interaction
between TAT peptide and negatively-charged DOPC/DOPS mixture
lipid bilayer, using neutron lamellar diffraction. The results unambig-
uously showed that the interaction of TAT peptide with anionic lipid
bilayers took place at two locations. One was in the peripheral aque-
ous phase between the adjacent bilayers and the second one was
below the glycerol backbone region of the lipid bilayer. In addition,
we found that TAT peptide carpeted the glycerol backbone region of
the lipid bilayer over all the peptide concentrations investigated. A
concentration-independent membrane thinning above a peptide con-
centration threshold (1 mol%) and a contiguous transbilayer water
channel at the largest peptide concentration (10 mol%) were also
found. This evidence led to the suggestion that the toroidal pore
model might be involved in the transmembrane mechanism of TAT
peptide. Moreover, we interpreted the surface peptide distribution
in the peripheral aqueous phase as a massive exclusion of TAT peptide
from its intrinsic location below the glycerol backbone region of the
bilayer. This was due to the electrostatic attractions between the
negatively-charged headgroups of phospholipid and the positively
charged TAT peptides. It consequently further led to the argument
that the role negative-charged headgroups of DOPS lipid play in the
transmembrane of TAT peptide is less important than previously
thought. To test this hypothesis, further neutron diffractions experi-
ments focusing on the interaction between TAT peptide and neutral
zwitterionic phospholipids like DOPC will be conducted in the future.
And more precise investigations using a TAT peptide with the deuter-
ated fragment on the C-terminal and N-terminal side will also be car-
ried out. The localization of these labels will provide the exact
orientation information of TAT peptide inside the bilayers. It is
hoped that our data presented here will stimulate further structure
studies on the transmembrane of TAT peptide, like molecular dynam-
ics simulations.Acknowledgement
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